QA: Epizyme Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001571498_2020_Epizyme_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001571498, Epizyme Inc

  xvar xval
0 AssetsCurrent 399,177,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,219,000
3 remainder_Assets 23,193,000
4 LiabilitiesCurrent 34,386,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 99,717,170
9 ResearchAndDevelopmentExpense 138,876,064
10 remainder_Expenses 57,660
11 remainder_Revenues 24,024,998
12 remainder_NetIncome 5,994,651
13 remainder_ComprehensiveNetIncome 29,551
  yvar yval
0 Assets 424,589,000
1 Liabilities 34,386,000
2 Expenses 238,650,894
3 Revenues 24,024,998
4 StockholdersEquity 390,203,000
5 NetIncome -208,631,245
6 ComprehensiveNetIncome -208,616,470
7 BaseVar 363,837,547
8 EconomicCapitalRatiobeforeLimitedLiability 2.80
9 EconomicCapitalRatio 3.55

Edgar->Model Mapping

Feature Distribution

Change over Time